https://mirror.vjregenmed.com The Video Journal of Regenerative Medicine Wed, 25 Aug 2021 11:23:12 +0000 en-US hourly 1 https://wordpress.org/?v=6.5.2 https://d2xz56kaqxj8if.cloudfront.net/wp-content/uploads/2023/09/12102509/VJR-Favicon.png https://mirror.vjregenmed.com 32 32 https://mirror.vjregenmed.com/video/bqgdtx36kco-meta-analysis-anti-bcma-car-t-in-rr-myeloma/ Thu, 08 Oct 2020 14:08:13 +0000 http://13.40.107.223/video/bqgdtx36kco-meta-analysis-anti-bcma-car-t-in-rr-myeloma/ Nico Gagelmann, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, discusses the results from the meta-analysis evaluating the outcomes of anti-BCMA CAR T-cell therapy in relapsed/refractory (R/R) multiple myeloma. This interview was recorded via an online conference call with The Video Journal of Regenerative Medicine (VJRegenMed).

]]> https://mirror.vjregenmed.com/video/uwvzi2z7nd8-car-t-cells-current-climate-future-perspectives-in-myeloma/ Thu, 08 Oct 2020 14:08:11 +0000 http://13.40.107.223/video/uwvzi2z7nd8-car-t-cells-current-climate-future-perspectives-in-myeloma/ Nico Gagelmann, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, provides an outlook on the current CAR-T climate for multiple myeloma, and where things might move in the future, including longer follow up, new targets, as well as allogeneic CAR T-cell approaches. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

]]>